BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2748454)

  • 1. A morphometric method to discriminate normal from dysplastic/carcinoma in situ squamous epithelium in the human esophagus.
    Lindholm J; Rubio CA; Kato Y; Hata J
    Pathol Res Pract; 1989 Mar; 184(3):297-305. PubMed ID: 2748454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia.
    Shirakawa Y; Naomoto Y; Kimura M; Kawashima R; Yamatsuji T; Tamaki T; Hamada M; Haisa M; Tanaka N
    Clin Cancer Res; 2000 Feb; 6(2):541-50. PubMed ID: 10690537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of early esophageal carcinoma and squamous epithelial dysplasia.
    Kuwano H; Baba K; Ikebe M; Adachi Y; Toh Y; Sugimachi K
    Hepatogastroenterology; 1993 Jun; 40(3):222-5. PubMed ID: 8325586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus.
    Kuwano H; Watanabe M; Sadanaga N; Ikebe M; Mori M; Sugimachi K
    Cancer Lett; 1993 Aug; 72(3):141-7. PubMed ID: 8402583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructure of squamous epithelium in esophageal dysplasia and squamous cell cancer].
    Fedotovskikh GV; Kolycheva NI; Aleksandrova NM; Zumerov EL
    Arkh Patol; 1985; 47(8):52-8. PubMed ID: 4074148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
    Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
    J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology and ultrastructure of the human esophageal epithelium. I. Normal and parakeratotic epithelium.
    Ferey L; Herlin P; Marnay J; Jacob JH; De Raucourt D; Gignoux M; Segol P; Ollivier JM; Mandard AM
    J Submicrosc Cytol; 1985 Oct; 17(4):651-65. PubMed ID: 4078951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal dysplasia. Assessment by light microscopy and scanning electron microscopy.
    Goran DA; Shields HM; Bates ML; Zuckerman GR; DeSchryver-Kecskemeti K
    Gastroenterology; 1984 Jan; 86(1):39-50. PubMed ID: 6689673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative study on esophageal cytology. I. Quantitative morphologic studies of normal, dysplastic and malignant squamous cells].
    Xiang YV
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):92-4. PubMed ID: 2401184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative study on esophageal cytology. II. Measurement of DNA contents of normal, dysplastic and malignant squamous cells of the esophagus].
    Xiang YY
    Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):342-4. PubMed ID: 2276324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse pagetoid squamous cell carcinoma in situ of the esophagus: a case report.
    Chu P; Stagias J; West AB; Traube M
    Cancer; 1997 May; 79(10):1865-70. PubMed ID: 9149010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
    Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
    Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system.
    Kumagai Y; Monma K; Kawada K
    Endoscopy; 2004 Jul; 36(7):590-4. PubMed ID: 15243880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological and cytophotometric characteristics of esophageal dysplasias and cancer in situ].
    Aleksandrova NM; Kolycheva NI; Adil'gireeva SKh
    Vopr Onkol; 1980; 26(1):41-6. PubMed ID: 7355595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two autopsy cases associated with a latent superficial carcinoma of esophagus].
    Takiyama W; Moriwaki S; Mandai K; Hara K; Doihara H; Takashima S
    Gan No Rinsho; 1989 Jul; 35(8):933-8. PubMed ID: 2545939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma.
    Shimizu M; Ban S; Odze RD
    Gastroenterol Clin North Am; 2007 Dec; 36(4):797-811, v-vi. PubMed ID: 17996791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA profiles in dysplasia and carcinoma of the human esophagus.
    Rubio CA; Auer GU; Kato Y; Liu FS
    Anal Quant Cytol Histol; 1988 Jun; 10(3):207-10. PubMed ID: 3408547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
    Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
    Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus.
    Shimizu Y; Yoshida T; Kato M; Hirota J; Ono S; Nakagawa M; Kobayashi T; Kubota K; Asaka M
    J Gastroenterol Hepatol; 2010 Feb; 25(2):314-8. PubMed ID: 19968747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.